(19)
(11) EP 1 100 914 A2

(12)

(88) Date of publication A3:
29.06.2000

(43) Date of publication:
23.05.2001 Bulletin 2001/21

(21) Application number: 99944319.5

(22) Date of filing: 02.08.1999
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/86, C12N 5/10, C07K 14/47, C07K 16/18, A61K 31/70, A61K 48/00, G01N 33/53
(86) International application number:
PCT/EP9905/566
(87) International publication number:
WO 0008/145 (17.02.2000 Gazette 2000/07)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 03.08.1998 US 128310

(71) Applicants:
  • Novartis AG
    4058 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

    AT 

(72) Inventors:
  • COOKE, Michael, Paul
    Del Mar, CA 92014 (US)
  • HOLNESS, Claire, Louise
    Palo Alto, CA 94306 (US)
  • SIRENKO, Oksana Ivanivna
    Belmont, CA 94002 (US)

(74) Representative: Becker, Konrad 
Novartis AGCorporate Intellectual PropertyPatent- und Markenabteilung
4002 Basel
4002 Basel (CH)

   


(54) NOVEL GENES IN CONTROL OF HEMATOPOIESIS